DIACEUTICS PLC (DXRX) — Full Year 2023 Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the DIACEUTICS PLC full year twenty twenty three results investor presentation. Throughout the recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time via the q and a tab situated at the right hand corner of your screen. Type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all the questions submitted today and publish responses as appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to Ryan Keeling, CEO. Good afternoon to you, sir. Good afternoon. And thank you, Alessandro. I'm joined today by my colleague and CFO, Nick Roberts. I, as I've been introduced, I'm the CEO of DIACEUTICS. And welcome to you all. For those who have followed the business, thank you. And, hopefully, today will serve as a a good update, to what we're doing here at DIACEUTICS and the problem that we're solving for the industry. For those who are new to the story, I'll try to guide you through what what are key differentiators and and the the value proposition that that we bring in this investment case. Next, go to drive the slides. So I'll ask you to go to slide three, please. We continue to refine and reflect on the key purpose and mission of this business. You'll see a headline on this slide which talks to a very simple message, which is that we help pharma to find patients. When you think about what a a pharmaceutical company does, big or small, they are effectively engaged in developing new therapeutics, bringing new drugs to market, or indeed when they get approval, trying to locate patients who are eligible for that therapy,...